These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 20061161)
21. Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors. Navidpour L; Amini M; Shafaroodi H; Abdi K; Ghahremani MH; Dehpour AR; Shafiee A Bioorg Med Chem Lett; 2006 Sep; 16(17):4483-7. PubMed ID: 16806914 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors. Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Ortuso F; Alcaro S; Cirilli R Eur J Med Chem; 2010 Dec; 45(12):6135-8. PubMed ID: 20974503 [TBL] [Abstract][Full Text] [Related]
23. Selective COX-2 inhibitors. Part 1: synthesis and biological evaluation of phenylazobenzenesulfonamides. Tsai WJ; Shiao YJ; Lin SJ; Chiou WF; Lin LC; Yang TH; Teng CM; Wu TS; Yang LM Bioorg Med Chem Lett; 2006 Sep; 16(17):4440-3. PubMed ID: 16814546 [TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity. Biava M; Porretta GC; Poce G; Supino S; Forli S; Rovini M; Cappelli A; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Vivoli E; Makovec F; Anzellotti P; Patrignani P; Anzini M J Med Chem; 2007 Nov; 50(22):5403-11. PubMed ID: 17915854 [TBL] [Abstract][Full Text] [Related]
25. Design, syntheses, biological evaluation, and docking studies of 2-substituted 5-methylsulfonyl-1-phenyl-1H-indoles: potent and selective in vitro cyclooxygenase-2 inhibitors. Cruz-López O; Díaz-Mochón JJ; Campos JM; Entrena A; Núñez MT; Labeaga L; Orjales A; Gallo MA; Espinosa A ChemMedChem; 2007 Jan; 2(1):88-100. PubMed ID: 17131462 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors. Dündar Y; Unlü S; Banoğlu E; Entrena A; Costantino G; Nuñez MT; Labeaga L; Sahin MF; Noyanalpan N Eur J Med Chem; 2009 May; 44(5):1830-7. PubMed ID: 19084295 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study. El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309 [TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of new 1,3-benzdiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Zarghi A; Zebardast T; Hajighasemali F; Alipoor E; Daraie B; Hedayati M Arch Pharm (Weinheim); 2012 Apr; 345(4):257-64. PubMed ID: 22076641 [TBL] [Abstract][Full Text] [Related]
29. Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides. Lin SJ; Tsai WJ; Chiou WF; Yang TH; Yang LM Bioorg Med Chem; 2008 Mar; 16(5):2697-706. PubMed ID: 18063374 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894 [TBL] [Abstract][Full Text] [Related]
31. Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors. Eren G; Unlü S; Nuñez MT; Labeaga L; Ledo F; Entrena A; Banoğlu E; Costantino G; Sahin MF Bioorg Med Chem; 2010 Sep; 18(17):6367-76. PubMed ID: 20692174 [TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazoles. Handler N; Jaeger W; Kuen-Krismer B; Erker T Arch Pharm (Weinheim); 2005 Dec; 338(12):602-4. PubMed ID: 16353278 [TBL] [Abstract][Full Text] [Related]
33. Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity. Unsal-Tan O; Ozadali K; Piskin K; Balkan A Eur J Med Chem; 2012 Nov; 57():59-64. PubMed ID: 23047224 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors. Lai Y; Ma L; Huang W; Yu X; Zhang Y; Ji H; Tian J Bioorg Med Chem Lett; 2010 Dec; 20(24):7349-53. PubMed ID: 21055929 [TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis, and Biological Evaluation of New 2-Phenyl-4H-chromen-4-one Derivatives as Selective Cyclooxygenase-2 Inhibitors. Zarghi A; Kakhki S Sci Pharm; 2015; 83(1):15-26. PubMed ID: 26839798 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors. Chen QH; Rao PN; Knaus EE Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011 [TBL] [Abstract][Full Text] [Related]
37. Isomeric acetoxy analogs of celecoxib and their evaluation as cyclooxygenase inhibitors. Abdur Rahim M; Praveen Rao PN; Bhardwaj A; Kaur J; Huang Z; Knaus EE Bioorg Med Chem Lett; 2011 Oct; 21(20):6074-80. PubMed ID: 21890358 [TBL] [Abstract][Full Text] [Related]
38. N-1 and C-3 substituted indole Schiff bases as selective COX-2 inhibitors: synthesis and biological evaluation. Kaur J; Bhardwaj A; Huang Z; Knaus EE Bioorg Med Chem Lett; 2012 Mar; 22(6):2154-9. PubMed ID: 22361134 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and pharmacological evaluation of 4-[2-alkylthio-5(4)-(4-substitutedphenyl)imidazole-4(5)yl]benzenesulfonamides as selective COX-2 inhibitors. Salimi M; Ghahremani MH; Naderi N; Amini M; Salimi E; Amanlou M; Abdi K; Salehi R; Shafiee A Acta Pharmacol Sin; 2007 Aug; 28(8):1254-60. PubMed ID: 17640491 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and biological evaluation of (E)-3-(4-methanesulfonylphenyl)-2-(aryl)acrylic acids as dual inhibitors of cyclooxygenases and lipoxygenases. Moreau A; Chen QH; Praveen Rao PN; Knaus EE Bioorg Med Chem; 2006 Dec; 14(23):7716-27. PubMed ID: 16931030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]